Quarterly compliance certificate under SEBI Depositories Regulations

Compliance View source PDF Explain this filing

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.3%Reaction day

₹526.95

prior close

₹530.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%-2.0% vs market

Pharmaceuticals peers, median of 172sector+0.0%-1.3% vs sector

On the reaction day the stock moved 2.0 pts less than Nifty Microcap 250 and 1.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.4

10m

-1.3

15m

-1.2

30m

-0.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.3+0.7-2.0+0.0-1.3

Next day

-0.8-1.0+0.2-0.8+0.0

-3.0-0.3-2.7-0.6-2.4

-4.4-1.9-2.4-1.9-2.5

-2.5-4.5+2.0-3.5+1.1

-8.3-5.5-2.9-4.4-3.9

-9.5-7.3-2.2-4.3-5.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Unichem Laboratories submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate, issued by Registrar and Share Transfer Agent MUFG Intime India, confirms that securities received from depository participants for dematerialisation were processed within prescribed timelines. It also confirms that security certificates were mutilated and cancelled after verification, and the depositories were substituted as registered owners in the register of members. This is a routine regulatory filing.

Likely market impact

Routine quarterly compliance filing with no material impact on shareholders or stock price.